Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 
 


Keywords

2023-05-26 02:15:41| Engadget

Turns out Elon Musk's FDA prediction was only off by about a month. After reportedly denying the company's overtures in March, the FDA approved Neuralink's application to begin human trials of its prototype Link brain-computer interface (BCI) on Thursday. Founded in 2016, Neuralink aims to commercialize BCIs in wide-ranging medical and therapeutic applications from stroke and spinal cord injury (SCI) rehabilitation, to neural prosthetic controls, to the capacity "to rewind memories or download them into robots," Neuralink CEO Elon Musk promised in 2020. BCIs essentially translate the analog electrical impulses of your brain (monitoring it using hair-thin electrodes delicately threaded into that grey matter) into the digital 1's and 0's that computers understand. Since that BCI needs to be surgically installed in a patient's noggin, the FDA which regulates such technologies requires that companies conduct rigorous safety testing before giving its approval for commercial use. In March, the FDA rejected Neuralink's application to begin human trials reportedly in part due to all the test animals that kept dying after having the prototype BCI implanted. According to internal documents acquired by Reuters in December, more than 1,500 animals had been killed in the development of the Neuralink BCI since 2018. The US Department of Agriculture's (USDA) Inspector General has since launched an investigation into those allegations.  The FDA's reticence was also born from concerns about the design and function of the interface when implanted in humans. "The agencys major safety concerns involved the devices lithium battery; the potential for the implants tiny wires to migrate to other areas of the brain; and questions over whether and how the device can be removed without damaging brain tissue," current and former Neuralink employees told Reuters in March.While Neuralink has obtained FDA approval to begin its study, the company is not yet seeking volunteers. This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people," Neuralink Tweeted on Thursday. "Recruitment is not yet open for our clinical trial."  This article originally appeared on Engadget at https://www.engadget.com/neuralink-receives-fda-clearance-to-begin-human-trials-of-its-brain-computer-interface-001504243.html?src=rss


Category: Marketing and Advertising

 

Latest from this category

04.07Otriums AI models give unsold fashion a second chance
03.07Top 10 Favorite Creator-Led Brands [Infographic]
03.07AI Update, July 3, 2025: AI News and Views From the Past Week
03.07The Power of Emotional Advertising in B2B Brand-Building: Feelings vs. Function
03.07In Relooted, gamers plan the perfect heist to reclaim Africas stolen artifacts
02.07The State of Hybrid Work
02.07Thought Leadership for Lead Generation: A Smart Key for Unlocking Transformational Growth
01.07Eight Less Traditional Ways People Are Using AI at Work
Marketing and Advertising »

All news

05.07Council tax plan could 'reduce' help for poorest
05.07Charity warns of unprecedented food demand
05.07Plans for Tru by Hilton hotel advance near I-80, La Grange Road exchange
05.07How to avoid creating AI zombies in your workplace
05.07Crying at work: A sign of strength, weakness or just being human?
05.07Today in History: Roosevelt signs the National Labor Relations Act
05.07How AI is transforming corporate finance
05.07NSE vs BSE: How the two stock exchanges fared on financial parameters in FY25
More »
Privacy policy . Copyright . Contact form .